Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hong

Showing results (41-50 of 272) with videos related to

Pageof 28
Sort By:
Psychiatry Research. Neuroimaging|May 26, 2021
Cortical gray matter structure in boys with Klinefelter syndromeLara C Foland-Ross, Maureen Gil, Sharon Bade Shrestha, et al.
Cancer|January 24, 2009
Survival of patients in a Phase 1 Clinic: the M. D. Anderson Cancer Center experienceJennifer Wheler, Apostolia M Tsimberidou, David Hong, et al.
Anti-Cancer Drugs|August 2, 2007
The geldanamycin analogue 17-allylamino-17-demethoxygeldanamycin inhibits the growth of GL261 glioma cells in vitro and in vivoElizabeth W Newcomb, Yevgeniy Lukyanov, Tona Schnee, et al.
Proteomics. Clinical Applications|April 23, 2010
Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patientsXianyin Lai, Robert L Bacallao, Bonnie L Blazer-Yost, et al.
Cancer Chemotherapy and Pharmacology|June 2, 2009
Phase 1 first-in-human clinical study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumorsApostolia Maria Tsimberidou, Michelle A Rudek, David Hong, et al.
Plos Pathogens|May 3, 2018
Transcriptional repression by ApiAP2 factors is central to chronic toxoplasmosisJoshua B Radke, Danielle Worth, David Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worseRajul K Jain, J Jack Lee, David Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Change in tumor size by RECIST correlates linearly with overall survival in phase I oncology studiesRajul K Jain, J Jack Lee, Chaan Ng, et al.
AJR. American Journal of Roentgenology|November 5, 2025
Image-Guided Thermal Ablation in Patients With Locally Recurrent Non-Small Cell Lung Cancer After Stereotactic-Beam Radiation TherapyMichelle Mai, Hyeonseon Kim, Abdifatah Omar, et al.
Trends in Parasitology|July 7, 2021
Anti-Wolbachia drugs for filariasisKelly L Johnston, W David Hong, Joseph D Turner, et al.
Pageof 28

Showing results (41-50 of 272) with videos related to

Sort By:
Pageof 28
Psychiatry Research. Neuroimaging|May 26, 2021
Cortical gray matter structure in boys with Klinefelter syndromeLara C Foland-Ross, Maureen Gil, Sharon Bade Shrestha, et al.
Cancer|January 24, 2009
Survival of patients in a Phase 1 Clinic: the M. D. Anderson Cancer Center experienceJennifer Wheler, Apostolia M Tsimberidou, David Hong, et al.
Anti-Cancer Drugs|August 2, 2007
The geldanamycin analogue 17-allylamino-17-demethoxygeldanamycin inhibits the growth of GL261 glioma cells in vitro and in vivoElizabeth W Newcomb, Yevgeniy Lukyanov, Tona Schnee, et al.
Proteomics. Clinical Applications|April 23, 2010
Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patientsXianyin Lai, Robert L Bacallao, Bonnie L Blazer-Yost, et al.
Cancer Chemotherapy and Pharmacology|June 2, 2009
Phase 1 first-in-human clinical study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumorsApostolia Maria Tsimberidou, Michelle A Rudek, David Hong, et al.
Plos Pathogens|May 3, 2018
Transcriptional repression by ApiAP2 factors is central to chronic toxoplasmosisJoshua B Radke, Danielle Worth, David Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worseRajul K Jain, J Jack Lee, David Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Change in tumor size by RECIST correlates linearly with overall survival in phase I oncology studiesRajul K Jain, J Jack Lee, Chaan Ng, et al.
AJR. American Journal of Roentgenology|November 5, 2025
Image-Guided Thermal Ablation in Patients With Locally Recurrent Non-Small Cell Lung Cancer After Stereotactic-Beam Radiation TherapyMichelle Mai, Hyeonseon Kim, Abdifatah Omar, et al.
Trends in Parasitology|July 7, 2021
Anti-Wolbachia drugs for filariasisKelly L Johnston, W David Hong, Joseph D Turner, et al.
Pageof 28